Dr. David L. Palchak

Dr. Wei Bai grew up in Beijing, China. In 1995, she graduated from Peking University Health Science Center (previously known as Beijing Medical University) with distinction. She then pursued graduate study in the United States. Upon receiving her master’s degree in Molecular Medicine from the University of Massachusetts Medical School in 1998, Dr. Bai joined a leading biotech company, Genentech, Inc., in South San Francisco to pursue her passion in translational research. She participated in research and development of several cancer drugs, including trastuzumab (Herceptin), bevacizumab (Avastin), and erlotinib (Tarceva), among others in the company pipeline.Excited to bring bench research to bedside practice, Dr. Bai ultimately transitioned to direct patient care in 2005. She completed her Internal Medicine residency at NewYork-Presbyterian Lower Manhattan Hospital in 2008, which included several months of clinical rotation at Memorial loan Kettering Cancer Center (MSKCC). Dr. Bai’s experience at MSKCC further enforced her commitment to oncology research and practice. She proceeded to a combined Hematology and Medical Oncology fellowship at Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC from 2008 to 2011.After her fellowship, Dr. Bai practiced hematology and medical oncology in the Samaritan Health System in Oregon. During her nine years with Samaritan, she treated patients with a wide range of cancer types and blood diseases. She served her patients with PRIDE — passion, respect, integrity, dedication and excellence. Dr. Bai was also active in clinical trials and resident education.Since 2020, Dr. Bai joined the team at Mission Hope Cancer Center. Compassionate and calm, she is devoted to each individual patient’s needs and goals. Dr. Bai is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Deep Vein Thrombosis, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Hemochromatosis.

Dr. Gorgun Akpek (Dr. G) is a board certified hematologist and medical oncologist who treats his patients with all types of cancer and blood related.Dr. Akpek received his MD degree from Hacettepe University, the top medical school in Turkey and did his internal medicine residency and hematology & medical oncology clinical fellowship trainings at Hacettepe University and Boston University Medical Centers. He became further specialized in Leukemia and Stem Cell/Bone Marrow Transplantation at Johns Hopkins University Department of Oncology in Baltimore, Maryland.He joined the faculty first at Johns Hopkins University and then University of Maryland Greenebaum Cancer Center as a clinical investigator and attending physician.He continued his career as a founding Director of Leukemia and Stem Cell Transplantation/Cell Therapy programs at Banner MD Anderson Cancer Center in Gilbert, Arizona and more recently he served as the Section Chief of Blood and Marrow Transplant Program (BMT) at Rush University Medical Center in Chicago.Dr. Akpek is a member of American Society of Hematology (ASH), Clinical Oncology (ASCO) and Transplantation (ASBMT). He is nationally recognized for his research by more than 100 publications and clinical work in leukemia, lymphoma, MDS, multiple myeloma and stem cell transplantation.Board Certification:Oncology, Hematology, Internal MedicineMedical School:Hacettepe University School of MedicineInternal Medicine Residency:Hacettepe University School of MedicineFellowship Training:Hacettepe University School of Medicine, Boston University Medical Center and Johns Hopkins UniversityAreas of Interest:All Cancers including: Autoimmune Cancer, Lung Cancer, Breast Cancer, Colon Cancer, Rectal Cancer,  Pancreatic Cancer, Gallbladder Cancer, Bladder Cancer, Ovarian Cancer, MelanomaAdditional Education: Master of Public Health, Johns Hopkins Bloomberg School of Public Health 2005. Awards and Recognition: Chief's Hematology and Oncology Scholar Award, Boston University 1995-1997 Jo-Ann McCaleb Amyloid Research Award 1997 Henry Christian Award, American Federation of Medical Research 2002. Dr. Akpek is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Childhood Iron Deficiency Anemia, Bone Marrow Transplant, and Splenectomy.

Board Certified in Medical Oncology, Hematology and Internal Medicine, Dr. Kennedy provides compassionate care for patients at Mission Hope Cancer Center, and works collaboratively with all departments to provide patients with all aspects of cancer care. Dr. Kennedy is able to offer patients the most advanced treatment with enrollment in cutting edge clinical research studies. She has years of experience in the treatment and diagnosis of all cancers and provides her patients with individualized care for the best possible outcomes.An educator at heart, Dr. Kennedy has a passion for teaching her patients about their disease and how their treatments work. Understanding a disease is empowering for the patient and can remove some of the fear associated with a cancer diagnosis.Dr. Kennedy received her medical degree from the University of Oklahoma. She completed her Internal Medicine residency at the University of California Davis, and Hematology-Oncology fellowship program at the University of Oklahoma Health Sciences Center-Stephenson Cancer Center.As an experienced principal investigator on numerous clinical trials for cancer therapies, Dr. Kennedy has published her findings in national medical journals, and puts her research knowledge into practice when treating patients. Dr. Kennedy is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, Anal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.